Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Melanoma 146Carcinoma, Non-Small-Cell Lung 112Carcinoma, Renal Cell 74Neoplasm Metastasis 53Carcinoma, Hepatocellular 51Squamous Cell Carcinoma of Head and Neck 50Lung Neoplasms 48Colorectal Neoplasms 34Pancreatic Neoplasms 30Neoplasms 30Hodgkin Disease 30Urinary Bladder Neoplasms 24Sarcoma 23Brain Neoplasms 23Stomach Neoplasms 22Head and Neck Neoplasms 21Breast Neoplasms 21Prostatic Neoplasms 20Carcinoma, Transitional Cell 20Glioblastoma 19Recurrence 17Colonic Neoplasms 17Kidney Neoplasms 16Uveal Melanoma 15Small Cell Lung Carcinoma 15Multiple Myeloma 15Esophageal Neoplasms 15Carcinoma, Squamous Cell 14Skin Neoplasms 13Leukemia, Myeloid, Acute 13

Interventions

Pemetrexed 2Nivolumab 2Cisplatin 2Carboplatin 2tepotinib 1pembrolizumab 1lazertinib 1durvalumab 1atezolizumab 1Taxes 1Radiotherapy 1Radiosurgery 1Ipilimumab 1BO-112 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Non-Small Cell Lung Cancer Metastatic × Nivolumab × Clear all
NCT03469960 2025-11-18

DICIPLE

Intergroupe Francophone de Cancerologie Thoracique

Phase 3 Completed
265 enrolled
Thoracic

Non-Small Cell Lung Cancer Metastatic

NCT05265650 2022-07-19

Noelia

Clinica Universidad de Navarra, Universidad de Navarra

Phase 1/2 Unknown
30 enrolled
Thoracic

Non-Small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡